Fig. 4From: Identify glioma recurrence and treatment effects with triple-tracer PET/CTA representative patient with TrE. Contrast MR image (a) presents an enhanced lesion with slightly increased uptake of 18F-FDOPA (b) and no increased uptake of 13N-NH3 (c) and 18F-FDG (d). Follow-up MR revealed that the enhanced lesions gradually decreased and disappeared (e, f)Back to article page